BN Business News
Add your company to Business Communicator →

Business · 29/09/2021

FDA Announces Draft Guidance for Developing Drugs to Treat Nontuberculous Mycobacterial Pulmonary Disease

The FDA is releasing a draft guidance to help pharmaceutical companies develop treatments for nontuberculous mycobacterial pulmonary disease caused by Mycobacterium avium complex.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights